icon
An official government website affiliated with the Government of the Kingdom of Saudi Arabia.
icon Thu 25 Jun 2026
Beta version
icon
Official Saudi government website domains end with gov.sa

All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.

icon
Government websites use the protocol. HTTPS for encryption and security.

All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.

icon
Registered with the Digital Government Authority under number:
20250831619
Suggestions

News

4
icon 2026-03-10

SFDA Grants Breakthrough Designation to "Bemlayo" for Adults with Obesity or Overweight

The Saudi Food and Drug Authority (SFDA) has granted Eli Lilly Breakthrough designation to Bemlayo (Orforglipron), which is indicated as an adjunct to...
More
4
icon 2026-03-03

SFDA Grants Orphan Drug Designation to "Agamree" for Duchenne Muscular Dystrophy

The Saudi Food and Drug Authority (SFDA) has granted Santhera Pharmaceuticals orphan drug designation to Agamree (vamorolone), which is indicated for...
More
4
icon 2026-03-02

SFDA Grants Orphan Drug Designation to "HYRNUO" for Advanced Non-Small Cell Lung Cancer

The Saudi Food and Drug Authority (SFDA) has granted Bayer orphan drug designation to Hyrnuo (Sevabertinib), which is indicated for the treatment of...
More
576
icon 2026-02-17

SFDA Expands Partnership with Indonesia’s Halal Product Assurance Organizing Agency

On the sidelines of the third Makkah Halal Forum, held February 14–16 at the Makkah Chamber Exhibitions and Events Center, the Saudi Food and Drug...
More
SFDA Grants Orphan Drug Designation to “Jascayd”
icon 2026-01-29

SFDA Grants Orphan Drug Designation to “Jascayd”

The Saudi Food and Drug Authority (SFDA) has granted Boehringer Ingelheim orphan drug designation to Jascayd (nerandomilast), which is indicated for...
More
SFDA Grants Orphan Drug Designation to “Sephience”
icon 2026-01-28

SFDA Grants Orphan Drug Designation to “Sephience”

The Saudi Food and Drug Authority (SFDA) has granted PTC Therapeutics orphan drug designation to Sephience (sepiapterin), which is indicated for the...
More